Entopsis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Investors
  • 4

Entopsis General Information

Description

Developer of novel diagnostic technologies designed to improve early detection and treatment of diseases. The company provides a universal platform to diagnose numerous diseases through urine samples, that outperforms liquid biopsies and consists of a series of time and cost-saving technologies for research and clinical testing, enabling the healthcare industry to access a suite of clinical tools that make diagnostic tests efficient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Decision/Risk Analysis
Corporate Office
  • The Foundry
  • 7600 Northwest 69th Avenue
  • Medley, FL 33166
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Entopsis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 19-Oct-2023 00.000 In Progress Generating Revenue
7. Later Stage VC (Series A) 01-Mar-2021 00.000 00.000 Completed Product Development
6. Secondary Transaction - Private 01-Jan-2019 00.000 Completed Product Development
5. Later Stage VC 10-Jan-2017 00000 00.000 Completed Product Development
4. Seed Round 18-Mar-2015 00000 00000 Completed Product Development
3. Product Crowdfunding 14-Sep-2014 0000 Completed Product Development
2. Grant 20-Feb-2014 $1K Completed Product Development
1. Grant 01-May-2012 $160K Completed Product Development
To view Entopsis’s complete valuation and funding history, request access »

Entopsis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel diagnostic technologies designed to improve early detection and treatment of diseases. The company pr
Diagnostic Equipment
Medley, FL
11 As of 2023
00.000
0000000000 0 00.000

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000 000000000
Palo Alto, CA
0000 As of 0000
00000
00000000 00000

00000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000
Menlo Park, CA
000 As of 0000
000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Entopsis Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guardant Health Formerly VC-backed Palo Alto, CA 0000 00000 00000000 00000
GRAIL Formerly VC-backed Menlo Park, CA 000 000 000000&0
Myriad Genetics Corporation Salt Lake City, UT 0000 00000 00000000 00000
Inivata Formerly VC-backed Cambridge, United Kingdom 00 00000 000000&0 00000
To view Entopsis’s complete competitors history, request access »

Entopsis Patents

Entopsis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4022284-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 0000000000
AU-2020340445-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 0000000000
CA-3152524-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 0000000000
US-20220398733-A1 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 0000000000
EP-4022284-A4 Detectable arrays for distinguishing analytes and diagnosis, and methods and systems related thereto Pending 29-Aug-2019 G01N33/57488 0
To view Entopsis’s complete patent history, request access »

Entopsis Executive Team (4)

Name Title Board Seat Contact Info
Obdulio Piloto Ph.D Co-Founder, Chief Executive Officer & Chairman
Chun Yi Huang Ph.D Chief Financial Officer, Partner & Board Member
Ian Cheong Ph.D Co-Founder & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Entopsis Board Members (3)

Name Representing Role Since
Chun Yi Huang Ph.D Entopsis Chief Financial Officer, Partner & Board Member 000 0000
Ian Cheong Ph.D Entopsis Co-Founder & Board Member 000 0000
Obdulio Piloto Ph.D Entopsis Co-Founder, Chief Executive Officer & Chairman 000 0000
To view Entopsis’s complete board members history, request access »

Entopsis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entopsis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Conversant Bio Corporation Minority 000 0000 000000 0
G3 Capital Partners Venture Capital Minority 000 0000 000000 0
The Awesome Foundation Other 000 0000 000000 0
Breakout Labs Not-For-Profit Venture Capital 000 0000 000000 0
To view Entopsis’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »